We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$393M
AUM Growth
+$20.1M
Cap. Flow
+$9.32M
Cap. Flow %
2.37%
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.3M
2
MRNA icon
Moderna
MRNA
+$5.95M
3
QCOM icon
Qualcomm
QCOM
+$4.24M
4
TAL icon
TAL Education Group
TAL
+$3.82M
5
AMD icon
Advanced Micro Devices
AMD
+$3.65M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$3.44M
2
KMB icon
Kimberly-Clark
KMB
+$2.7M
3
MCO icon
Moody's
MCO
+$2.68M
4
UPS icon
United Parcel Service
UPS
+$2.64M
5
SHW icon
Sherwin-Williams
SHW
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.91%
2 Technology 17.83%
3 Consumer Discretionary 11.15%
4 Industrials 9.32%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
376
LivaNova
LIVN
$4.43B
$331K 0.08%
+3,941
New +$325K
RUN icon
377
Sunrun
RUN
$2.38B
$331K 0.08%
+5,930
New +$286K
MAS icon
378
Masco
MAS
$16.4B
$327K 0.08%
5,559
-32,896
-86% -$2.03M
KL
379
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$327K 0.08%
8,494
+1,253
+17% +$50.2K
QRVO icon
380
Qorvo
QRVO
$7.92B
$325K 0.08%
1,659
+366
+28% +$67.5K
TREX icon
381
Trex
TREX
$4.57B
$325K 0.08%
3,178
+40
+1% +$4.04K
COLM icon
382
Columbia Sportswear
COLM
$3.25B
$324K 0.08%
+3,289
New +$345K
FBIN icon
383
Fortune Brands Innovations
FBIN
$6.14B
$324K 0.08%
3,806
-8,050
-68% -$704K
PWR icon
384
Quanta Services
PWR
$93.1B
$324K 0.08%
+3,580
New +$336K
STLA icon
385
Stellantis
STLA
$16.5B
$323K 0.08%
16,393
+4,952
+43% +$93.1K
ONC
386
BeOne Medicines Ltd
ONC
$33.8B
$323K 0.08%
940
+324
+53% +$107K
EMN icon
387
Eastman Chemical
EMN
$7.74B
$321K 0.08%
+2,746
New +$330K
VIAV icon
388
Viavi Solutions
VIAV
$9.41B
$318K 0.08%
17,981
+1,010
+6% +$17K
WEN icon
389
Wendy's
WEN
$1.39B
$318K 0.08%
+13,559
New +$311K
SYNA icon
390
Synaptics
SYNA
$4.55B
$317K 0.08%
+2,038
New +$276K
BR icon
391
Broadridge
BR
$17.7B
$316K 0.08%
1,954
-6,090
-76% -$973K
IIPR icon
392
Innovative Industrial Properties
IIPR
$1.78B
$316K 0.08%
+1,655
New +$304K
GMAB icon
393
Genmab
GMAB
$17.7B
$315K 0.08%
7,722
-3,178
-29% -$123K
MAN icon
394
ManpowerGroup
MAN
$2.5B
$313K 0.08%
+2,629
New +$310K
EQNR icon
395
Equinor
EQNR
$91.4B
$311K 0.08%
+14,679
New +$309K
FCFS icon
396
FirstCash
FCFS
$9.06B
$311K 0.08%
+4,063
New +$307K
BLKB icon
397
Blackbaud
BLKB
$1.59B
$310K 0.08%
+4,052
New +$292K
CP icon
398
Canadian Pacific Kansas City
CP
$81.1B
$308K 0.08%
4,000
-6,715
-63% -$521K
EEM icon
399
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$308K 0.08%
5,577
-12,670
-69% -$688K
FIVE icon
400
Five Below
FIVE
$11.5B
$305K 0.08%
+1,577
New +$301K

Similar funds

Y-Intercept (HK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
  • Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
  • Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
  • Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
  • Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
  • Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
  • Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.